LEXX
Lexaria Bioscience Corp.
NASDAQ · Healthcare · Biotechnology · CA
$2.60
−9.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.16x
- Price / sales
- 28.23x
- Price / cash flow
- -0.74x
Enterprise value
- Enterprise value
- $1.6M
- EV / sales
- 8.00x
- EV / EBITDA
- -0.20x
- EV / EBIT
- -0.20x
- Market cap
- $5.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026